Applied Genetics Technologies Corporation
1
1
0.05
1
- Areas of investment
Summary
In 1999 was created Applied Genetics Technologies Corporation, which is appeared as Corporate Investor. The company was established in North America in United States. The main department of described Corporate Investor is located in the Alachua.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Nanostream Inc., Nanostream Inc.. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2001.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Applied Genetics Technologies Corporation, startups are often financed by Techno Venture Management, Shamrock Capital Advisors. The meaningful sponsors for the fund in investment in the same round are Techno Venture Management, Shamrock Capital Advisors. In the next rounds fund is usually obtained by Techno Venture Management, Lilly Ventures, Flagship Pioneering.
The fund was created by Barry Byrne, Nicholas Muzyczka, Richard Samulski, Terence Flotte, William Hauswirth.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Rounds per year
- 0.05
- Investments by industry
- Medical (1)
- Biotechnology (1)
- Pharmaceutical (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2001
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Nanostream Inc. | 29 Mar 2001 | Biotechnology, Medical, Pharmaceutical | Early Stage Venture | 0 | United States, California, Pasadena |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.